ARCHIVES

Second-Generation CML Drugs Show Promise For Frontline

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

UNM Cancer Center Appoints Four Leaders

May 24, 2013

NIH Alternative Medicine Office Releases RFA For Grant Awards

April 9, 1993

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014

Maria Carolina Hinestrosa, EVP of National Breast Cancer Coalition

June 26, 2009

In Brief: Marasco New ACR President, Barbara Chick VP; Wolmark Named Surgeon In Chief Of Montefiore

October 10, 1986

Dramatic Increase In Third World Cancer Rates May Face National, International Organizations: Murphy

September 17, 1982